A trial looking at pravastatin with chemotherapy for non small cell lung cancer (LungstarPK)

Cancer type:

Lung cancer
Non small cell lung cancer

Status:

Results

Phase:

Phase 2

This trial was trying to find out more about having a statin drug at the same time as cisplatin and docetaxel for non small cell lung cancer.

More about this trial

Doctors use chemotherapy to treat advanced non small cell lung cancer. The chemotherapy drugs in this trial were two of the most commonly used.

Statins are medicines that people usually take to lower their cholesterol. We know from earlier research that they may also affect cancer cells. In this trial the researchers wanted to find out more about how a statin called pravastatin mixes with cisplatin and docetaxel.

The aims of the trial were to

  • Learn more about how the statin drug interacts with the chemotherapy drugs in your body
  • Find out about the side effects of having both treatments together

Summary of results

There are no results available for this trial. The researchers were unable to recruit enough patients.

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Dr Peter Schmid
Professor Michael J Seckl

Supported by

Experimental Cancer Medicine Centre (ECMC)
Sanofi

Questions about cancer? Contact our information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:

1707

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Around 1 in 5 people take part in clinical trials

3 phases of trials

Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.

Last reviewed:

Rate this page:

Currently rated: 1 out of 5 based on 2 votes
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page